Free Trial
NASDAQ:BJDX

Bluejay Diagnostics (BJDX) Stock Price, News & Analysis

Bluejay Diagnostics logo
$1.66 +0.04 (+2.16%)
Closing price 07/3/2025 03:35 PM Eastern
Extended Trading
$1.64 -0.01 (-0.60%)
As of 07/3/2025 04:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Bluejay Diagnostics Stock (NASDAQ:BJDX)

Key Stats

Today's Range
$1.62
$1.66
50-Day Range
$1.52
$2.25
52-Week Range
$1.46
$37.50
Volume
10,134 shs
Average Volume
661,737 shs
Market Capitalization
$2.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bluejay Diagnostics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
2nd Percentile Overall Score

BJDX MarketRank™: 

Bluejay Diagnostics scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Bluejay Diagnostics.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Bluejay Diagnostics is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Bluejay Diagnostics is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Bluejay Diagnostics has a P/B Ratio of 0.16. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Bluejay Diagnostics' valuation and earnings.
  • Percentage of Shares Shorted

    5.74% of the float of Bluejay Diagnostics has been sold short.
  • Short Interest Ratio / Days to Cover

    Bluejay Diagnostics has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bluejay Diagnostics has recently increased by 154.01%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Bluejay Diagnostics does not currently pay a dividend.

  • Dividend Growth

    Bluejay Diagnostics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.74% of the float of Bluejay Diagnostics has been sold short.
  • Short Interest Ratio / Days to Cover

    Bluejay Diagnostics has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bluejay Diagnostics has recently increased by 154.01%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Bluejay Diagnostics this week, compared to 0 articles on an average week.
  • Search Interest

    Only 1 people have searched for BJDX on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Bluejay Diagnostics to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Bluejay Diagnostics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.08% of the stock of Bluejay Diagnostics is held by insiders.

  • Percentage Held by Institutions

    Only 18.47% of the stock of Bluejay Diagnostics is held by institutions.

  • Read more about Bluejay Diagnostics' insider trading history.
Receive BJDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bluejay Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

BJDX Stock News Headlines

BJDX - Bluejay Diagnostics Inc Ownership - Morningstar
Have you heard of “E.I.”?
Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing to invest in new "E.I." Tech, which one expert estimates will grow by 200,000%. Becoming bigger than the automobile, PC, and cell phone markets... COMBINED!
Bluejay Diagnostics Inc BJDX
Bluejay Diagnostics announces abstract acceptance at 2025 SAEM meeting
See More Headlines

BJDX Stock Analysis - Frequently Asked Questions

Bluejay Diagnostics' stock was trading at $4.87 at the start of the year. Since then, BJDX stock has decreased by 66.0% and is now trading at $1.6550.

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) posted its quarterly earnings data on Tuesday, May, 13th. The company reported ($3.37) earnings per share (EPS) for the quarter.

Bluejay Diagnostics shares reverse split on Thursday, June 20th 2024.The 1-8 reverse split was announced on Thursday, June 20th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

Bluejay Diagnostics (BJDX) raised $22 million in an IPO on Wednesday, November 10th 2021. The company issued 2,160,000 shares at $10.00 per share.

Shares of BJDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bluejay Diagnostics investors own include SoFi Technologies (SOFI), Athenex (ATNX), V.F. (VFC), Allarity Therapeutics (ALLR), Andersons (ANDE) and British American Tobacco (BTI).

Company Calendar

Last Earnings
5/13/2025
Today
7/04/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BJDX
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$7.72 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$10.34 per share
Price / Book
0.16

Miscellaneous

Free Float
1,493,000
Market Cap
$2.47 million
Optionable
Not Optionable
Beta
0.47
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NASDAQ:BJDX) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners